Brendel Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.67M | Buy |
22,515
+349
| +2% | +$75.1K | 2.62% | 5 |
|
|
2026
Q1 | $4.82M | Sell |
22,166
-1,808
| -8% | -$401K | 2.39% | 12 |
|
|
2025
Q4 | $5.48M | Buy |
23,974
+1,066
| +5% | +$243K | 2.69% | 5 |
|
|
2025
Q3 | $5.3M | Buy |
22,908
+16,333
| +248% | +$3.33M | 2.72% | 3 |
|
|
2025
Q2 | $1.22M | Buy |
6,575
+20
| +0.3% | +$3.72K | 0.68% | 49 |
|
|
2025
Q1 | $1.37M | Sell |
6,555
-300
| -4% | -$58.3K | 0.83% | 43 |
|
|
2024
Q4 | $1.22M | Hold |
6,855
| – | – | 0.74% | 43 |
|
|
2024
Q3 | $1.35M | Hold |
6,855
| – | – | 0.77% | 44 |
|
|
2024
Q2 | $1.18M | Hold |
6,855
| – | – | 0.75% | 44 |
|
|
2024
Q1 | $1.25M | Hold |
6,855
| – | – | 1.43% | 26 |
|
|
2023
Q4 | $1.06M | Sell |
6,855
-95
| -1% | -$13.8K | 0.7% | 43 |
|
|
2023
Q3 | $1.04M | Sell |
6,950
-15
| -0.2% | -$2.2K | 1.54% | 22 |
|
|
2023
Q2 | $938K | Sell |
6,965
-575
| -8% | -$84.3K | 1.41% | 22 |
|
|
2023
Q1 | $1.2M | Sell |
7,540
-338
| -4% | -$51.7K | 0.89% | 40 |
|
|
2022
Q4 | $1.27M | Sell |
7,878
-422
| -5% | -$64.7K | 2.55% | 17 |
|
|
2022
Q3 | $1.11M | Sell |
8,300
-7,285
| -47% | -$1.05M | 2.65% | 15 |
|
|
2022
Q2 | $2.39M | Sell |
15,585
-6,498
| -29% | -$993K | 2.08% | 12 |
|
|
2022
Q1 | $3.58M | Sell |
22,083
-1,392
| -6% | -$202K | 1.95% | 16 |
|
|
2021
Q4 | $3.18M | Buy |
23,475
+15,255
| +186% | +$1.8M | 1.65% | 20 |
|
|
2021
Q3 | $887K | Hold |
8,220
| – | – | 1.06% | 34 |
|
|
2021
Q2 | $926K | Sell |
8,220
-6,420
| -44% | -$723K | 0.51% | 56 |
|
|
2021
Q1 | $1.58M | Buy |
14,640
+281
| +2% | +$30.1K | 1.06% | 34 |
|
|
2020
Q4 | $1.54M | Buy |
14,359
+6,139
| +75% | +$590K | 1.05% | 34 |
|
|
2020
Q3 | $720K | Hold |
8,220
| – | – | 0.58% | 47 |
|
|
2020
Q2 | $807K | Hold |
8,220
| – | – | 0.7% | 46 |
|
|
2020
Q1 | $626K | Hold |
8,220
| – | – | 0.74% | 42 |
|
|
2019
Q4 | $728K | Hold |
8,220
| – | – | 0.62% | 50 |
|
|
2019
Q3 | $622K | Hold |
8,220
| – | – | 0.56% | 51 |
|
|
2019
Q2 | $598K | Hold |
8,220
| – | – | 0.58% | 47 |
|
|
2019
Q1 | $662K | Hold |
8,220
| – | – | 0.59% | 46 |
|
|
2018
Q4 | $758K | Buy |
+8,220
| New | +$723K | 0.87% | 42 |
|
Other funds holding ABBV
Brendel Financial Advisors's ABBV Position: Q2 2026 in Review
Brendel Financial Advisors increased its AbbVie (ABBV) stake by 1.6% in Q2 2026, buying an estimated $75.1K and bringing the position to 22,515 shares worth $5.67M. The position accounts for 2.62% of the portfolio, ranked #5.
Brendel Financial Advisors first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Brendel Financial Advisors held 22,515 shares of AbbVie worth $5.67M as of Q2 2026.
- Brendel Financial Advisors bought 349 AbbVie shares in Q2 2026, an estimated $75.1K.
- AbbVie made up 2.62% of Brendel Financial Advisors's portfolio in Q2 2026, its #5 holding.
- Brendel Financial Advisors first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Brendel Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.